ANAPA BIOTECH A/S: Financial statements 2020
CVR: 27585167
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
ANAPA BIOTECH A/S (CVR 27585167) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 525,854 and a net result of DKK 472,071 compared with DKK -3,813,000 the year before. That is an increase of 405.6% compared with the year before. Equity in the 2020 report amounted to DKK 472,071. The solvency ratio was 31%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 525,854
- Profit/Loss
- DKK 472,071
- Equity
- DKK 472,071
- Total Assets
- DKK 1,521,885
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 526K | 472K | 472K | 1 |
| 2019 | - | 104K | -3.8M | 0 | 1 |
| 2018 | - | 236K | -693K | 3.8M | 1 |
| 2017 | - | 360K | -5.2M | 4.5M | 1 |
| 2016 | - | -219K | -27M | 9.7M | 1 |
Official annual report
How creditworthy is ANAPA BIOTECH A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ANAPA BIOTECH A/S has published its annual report for 2019. Gross profit came to DKK 104,000, and the net result was DKK -3,813,000.
As of April 24, 2020, EY Godkendt Revisionspartnerselskab has stepped down as auditor of ANAPA BIOTECH A/S.
As of February 19, 2020, Anne Margrethe Echwald has joined the board of directors of ANAPA BIOTECH A/S.
As of February 19, 2020, Søren Morgenthaler Echwald has joined the board of directors of ANAPA BIOTECH A/S.
As of February 19, 2020, Anette Kofod Echwald has joined the board of directors of ANAPA BIOTECH A/S.
As of February 19, 2020, Henrik Torkil Westh has left the board of directors of ANAPA BIOTECH A/S.
As of February 19, 2020, John Riis Mortensen has left the board of directors of ANAPA BIOTECH A/S.
As of February 19, 2020, Karim Tabiti has left the board of directors of ANAPA BIOTECH A/S.
As of February 19, 2020, Apana Holding ApS is registered as an owner of ANAPA BIOTECH A/S with an ownership share of 100%.
About ANAPA BIOTECH A/S
ANAPA BIOTECH A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2004. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named QUANTIBACT A/S and LNA BACTERIAL DETECTION A/S. The management consists of Søren Morgenthaler Echwald. The board consists of Anette Kofod Echwald (chair), Caroline Marie Morgenthaler Echwald and Søren Morgenthaler Echwald. The company is owned by Apana Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 263,027 and a net result of DKK 488,982 compared with DKK 7,646,635 the year before. Equity in the 2025 report amounted to DKK 10,970,173.